LAURA EFROS — Lobbyist Profile | Poliscope

LAURA EFROS

Filings

Clients

Firms

Years active

2019–2026

Associated filing income

—

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
BAVARIAN NORDIC INC	31	2019–2026

Lobbying firms

Firm	Filings	Years
BAVARIAN NORDIC INC	31	2019–2026

Original LDA source filings (31)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2026 · second_quarter · 2T

Firm income: —Client expense: $160,000Open original LDA filing ↗

Assigned issues and filing targets (4 issues)

HCR

Health Issues

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; PAHPA; Labor-HHS-ED appropriations bills; NDAA, tariffs

DEF

Defense

Source: Senate LDA

Show 27 more original filings

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2025 · second_quarter · Q2

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

PHA

Pharmacy

HCR

Health Issues

MED

Medical/Disease Research/Clinical Labs

DEF

Defense

DIS

Disaster Planning/Emergencies

HOM

Homeland Security

SCI

Science/Technology

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2025 · first_quarter · Q1

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

MED

Medical/Disease Research/Clinical Labs

DEF

Defense

DIS

Disaster Planning/Emergencies

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2024 · fourth_quarter · Q4

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

DIS

Disaster Planning/Emergencies

PHA

Pharmacy

MED

Medical/Disease Research/Clinical Labs

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2024 · third_quarter · Q3

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

DEF

Defense

SCI

Science/Technology

MED

Medical/Disease Research/Clinical Labs

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2024 · second_quarter · Q2

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

MED

Medical/Disease Research/Clinical Labs

HCR

Health Issues

DIS

Disaster Planning/Emergencies

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2024 · first_quarter · Q1

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

PHA

Pharmacy

HCR

Health Issues

DEF

Defense

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2023 · fourth_quarter · Q4

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

MED

Medical/Disease Research/Clinical Labs

SCI

Science/Technology

HOM

Homeland Security

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2023 · third_quarter · Q3

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

SCI

Science/Technology

DIS

Disaster Planning/Emergencies

MED

Medical/Disease Research/Clinical Labs

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2023 · second_quarter · Q2

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

DEF

Defense

PHA

Pharmacy

SCI

Science/Technology

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2023 · first_quarter · Q1

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

DIS

Disaster Planning/Emergencies

HOM

Homeland Security

HCR

Health Issues

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2022 · fourth_quarter · Q4

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

DEF

Defense

Biodefense; Biomedical Advanced Research and Development Authority funding; vaccine research, development, manufacturing and marketing; infectious diseases; cancer; PAHPA; Labor-HHS-ED appropriations bills

HOM

Homeland Security

PHA

Pharmacy

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2022 · third_quarter · Q3

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

PHA

Pharmacy

MED

Medical/Disease Research/Clinical Labs

HOM

Homeland Security

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2022 · second_quarter · Q2

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

HCR

Health Issues

DEF

Defense

DIS

Disaster Planning/Emergencies

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2022 · first_quarter · Q1

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

HCR

Health Issues

DEF

Defense

SCI

Science/Technology

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2021 · fourth_quarter · Q4

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

HOM

Homeland Security

DEF

Defense

SCI

Science/Technology

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2021 · third_quarter · Q3

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

HOM

Homeland Security

DEF

Defense

HCR

Health Issues

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2021 · second_quarter · Q2

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

MED

Medical/Disease Research/Clinical Labs

HCR

Health Issues

SCI

Science/Technology

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2021 · first_quarter · Q1

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

HOM

Homeland Security

HCR

Health Issues

DIS

Disaster Planning/Emergencies

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2020 · fourth_quarter · Q4

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

HOM

Homeland Security

HCR

Health Issues

DEF

Defense

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2020 · third_quarter · Q3

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

SCI

Science/Technology

MED

Medical/Disease Research/Clinical Labs

HCR

Health Issues

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2020 · second_quarter · Q2

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

MED

Medical/Disease Research/Clinical Labs

HOM

Homeland Security

DIS

Disaster Planning/Emergencies

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2020 · first_quarter · Q1

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

SCI

Science/Technology

DIS

Disaster Planning/Emergencies

PHA

Pharmacy

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2019 · fourth_quarter · Q4

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

SCI

Science/Technology

DEF

Defense

HOM

Homeland Security

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2019 · third_quarter · Q3

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

PHA

Pharmacy

SCI

Science/Technology

HCR

Health Issues

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2019 · second_quarter · Q2

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

DIS

Disaster Planning/Emergencies

PHA

Pharmacy

HOM

Homeland Security

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2019 · second_quarter · RA

Firm income: —Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

MED

Medical/Disease Research/Clinical Labs

Biodefense; Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing; infectious diseases, cancer, Labor-HHS-ED appropriations bills

SCI

Science/Technology

Biodefense; Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing; infectious diseases, cancer, Labor-HHS-ED appropriations bills

DIS

Disaster Planning/Emergencies

Biodefense; Biomedical Advanced Research and Development Authority funding, vaccine research, development, manufacturing and marketing; infectious diseases, cancer, Labor-HHS-ED appropriations bills

BAVARIAN NORDIC INC. via BAVARIAN NORDIC INC.

2019 · first_quarter · Q1

Firm income: —Client expense: $130,000Open original LDA filing ↗

Assigned issues and filing targets (7 issues)

HCR

Health Issues

DEF

Defense

DIS

Disaster Planning/Emergencies